Your session is about to expire
← Back to Search
Autologous Bone + Calcium Phosphate Cement for Anterior Cruciate Ligament (ACL)
N/A
Waitlist Available
Led By Eric Strauss, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 12 post-op
Awards & highlights
Study Summary
This trial is looking at whether using a bone-void filler to treat the bone defect left after harvesting the patellar tendon for ACL reconstruction affects anterior knee pain.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month 12 post-op
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 12 post-op
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Score on International Knee Documentation Committee (IKDC Questionnaire)
Score on Knee injury and Osteoarthritis Outcome Score (KOOS) Survey
Score on Kujala Anterior Knee Pain Scale (AKPS)
+1 moreTrial Design
3Treatment groups
Active Control
Placebo Group
Group I: Autologous Bone + Calcium Phosphate CementActive Control2 Interventions
Autologous bone plus calcium phosphate cement
Group II: Autologous Bone + DBMActive Control2 Interventions
Autologous bone plus demineralized bone matrix
Group III: ControlPlacebo Group1 Intervention
The control group will receive autologous bone obtained from the BTBPB graft harvest
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,369 Previous Clinical Trials
840,449 Total Patients Enrolled
Eric Strauss, MDPrincipal InvestigatorNYU Langone Health
5 Previous Clinical Trials
415 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still an opportunity to join this experiment?
"According to the information presented on clinicaltrials.gov, this trial has ceased its recruitment of participants; it was first posted online on August 31st 2020 and last amended on August 22nd 2022. Although no longer enrolling patients in this particular study, 6 other trials are actively seeking volunteers as we speak."
Answered by AI
Share this study with friends
Copy Link
Messenger